Global Viral Vector and Plasmid DNA Market Research Report 2023(Status and Outlook)
Report Overview
Viral vectors carry genetic material into cells by exploiting the molecular mechanisms by which viruses transmit their genomes to other cells for infection.It can occur in vivo or in vitro.Plasmid carriers are plasmids artificially constructed on the basis of natural plasmids to adapt to laboratory operations.In recent years, global viral vector and plasmid DNA manufacturing has developed rapidly, with a compound growth rate of about 28% during 2018-2018.In 2018, global sales of viral vector and plasmid DNA production reached $381 million.In 2018, China accounted for about 4% of global sales.In the next five years, the production of viral vectors and plasmid DNA products in China will continue to grow rapidly.Viral vector and plasmid DNA manufacturing are mainly divided into viral vector manufacturing and plasmid DNA manufacturing, among which viral vector manufacturing accounts for the largest proportion, accounting for nearly 38% of the total market in 2018.Viral vector and plasmid DNA manufacturing is mainly used for drug development and production of cancer, genetic diseases, viral infections and other diseases, among which cancer is the main application field, accounting for 35% in 2018.The market is highly competitive.Brammer Bio, Oxford BioMedica, Cobra Biologics, FinVector and Lonza are major suppliers.They have mastered key technologies and patents, and they have a fixed customer base. They have established a monopoly in the market.Gene therapy technology innovation and clinical trials have mushroomed in recent years, and a number of gene therapy projects have been approved for marketing in the United States, the European Union, China and other countries.The target of gene therapy has also been gradually expanded from single gene genetic diseases to malignant tumors, infectious diseases, cardiovascular diseases, autoimmune diseases, metabolic diseases and other major diseases.
The Global Viral Vector and Plasmid DNA Market Size was estimated at USD 667.50 million in 2022 and is projected to reach USD 2295.80 million by 2029, exhibiting a CAGR of 19.30% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Viral Vector and Plasmid DNA market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Viral Vector and Plasmid DNA Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Viral Vector and Plasmid DNA market in any manner.
Global Viral Vector and Plasmid DNA Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Brammer Bio
Oxford BioMedica
Cobra Biologics
FinVector
Lonza
BioReliance
MolMed
FUJIFILM Diosynth Biotechnologies
UniQure
Aldevron
Richter-Helm
Eurogentec
OBiO Technology
Yposkesi
Cell and Gene Therapy Catapult
MassBiologics
Biovian
VGXI
Gene Synthesis
PlasmidFactory
Jikai Gene
Market Segmentation (by Type)
Plasmid DNA
Viral Vector
Market Segmentation (by Application)
Packaging
Books & Catalogue
Advertising
Tags & Labels
Office Stationery
Magazines
Newspaper
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Viral Vector and Plasmid DNA Market
Overview of the regional outlook of the Viral Vector and Plasmid DNA Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Viral Vector and Plasmid DNA Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Viral Vector and Plasmid DNA
- 1.2 Key Market Segments
- 1.2.1 Viral Vector and Plasmid DNA Segment by Type
- 1.2.2 Viral Vector and Plasmid DNA Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Viral Vector and Plasmid DNA Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Viral Vector and Plasmid DNA Market Size (M USD) Estimates and Forecasts (2018-2029)
- 2.1.2 Global Viral Vector and Plasmid DNA Sales Estimates and Forecasts (2018-2029)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Viral Vector and Plasmid DNA Market Competitive Landscape
- 3.1 Global Viral Vector and Plasmid DNA Sales by Manufacturers (2018-2023)
- 3.2 Global Viral Vector and Plasmid DNA Revenue Market Share by Manufacturers (2018-2023)
- 3.3 Viral Vector and Plasmid DNA Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Viral Vector and Plasmid DNA Average Price by Manufacturers (2018-2023)
- 3.5 Manufacturers Viral Vector and Plasmid DNA Sales Sites, Area Served, Product Type
- 3.6 Viral Vector and Plasmid DNA Market Competitive Situation and Trends
- 3.6.1 Viral Vector and Plasmid DNA Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Viral Vector and Plasmid DNA Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Viral Vector and Plasmid DNA Industry Chain Analysis
- 4.1 Viral Vector and Plasmid DNA Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Viral Vector and Plasmid DNA Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Viral Vector and Plasmid DNA Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Viral Vector and Plasmid DNA Sales Market Share by Type (2018-2023)
- 6.3 Global Viral Vector and Plasmid DNA Market Size Market Share by Type (2018-2023)
- 6.4 Global Viral Vector and Plasmid DNA Price by Type (2018-2023)
- 7 Viral Vector and Plasmid DNA Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Viral Vector and Plasmid DNA Market Sales by Application (2018-2023)
- 7.3 Global Viral Vector and Plasmid DNA Market Size (M USD) by Application (2018-2023)
- 7.4 Global Viral Vector and Plasmid DNA Sales Growth Rate by Application (2018-2023)
- 8 Viral Vector and Plasmid DNA Market Segmentation by Region
- 8.1 Global Viral Vector and Plasmid DNA Sales by Region
- 8.1.1 Global Viral Vector and Plasmid DNA Sales by Region
- 8.1.2 Global Viral Vector and Plasmid DNA Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Viral Vector and Plasmid DNA Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Viral Vector and Plasmid DNA Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Viral Vector and Plasmid DNA Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Viral Vector and Plasmid DNA Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Viral Vector and Plasmid DNA Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Brammer Bio
- 9.1.1 Brammer Bio Viral Vector and Plasmid DNA Basic Information
- 9.1.2 Brammer Bio Viral Vector and Plasmid DNA Product Overview
- 9.1.3 Brammer Bio Viral Vector and Plasmid DNA Product Market Performance
- 9.1.4 Brammer Bio Business Overview
- 9.1.5 Brammer Bio Viral Vector and Plasmid DNA SWOT Analysis
- 9.1.6 Brammer Bio Recent Developments
- 9.2 Oxford BioMedica
- 9.2.1 Oxford BioMedica Viral Vector and Plasmid DNA Basic Information
- 9.2.2 Oxford BioMedica Viral Vector and Plasmid DNA Product Overview
- 9.2.3 Oxford BioMedica Viral Vector and Plasmid DNA Product Market Performance
- 9.2.4 Oxford BioMedica Business Overview
- 9.2.5 Oxford BioMedica Viral Vector and Plasmid DNA SWOT Analysis
- 9.2.6 Oxford BioMedica Recent Developments
- 9.3 Cobra Biologics
- 9.3.1 Cobra Biologics Viral Vector and Plasmid DNA Basic Information
- 9.3.2 Cobra Biologics Viral Vector and Plasmid DNA Product Overview
- 9.3.3 Cobra Biologics Viral Vector and Plasmid DNA Product Market Performance
- 9.3.4 Cobra Biologics Business Overview
- 9.3.5 Cobra Biologics Viral Vector and Plasmid DNA SWOT Analysis
- 9.3.6 Cobra Biologics Recent Developments
- 9.4 FinVector
- 9.4.1 FinVector Viral Vector and Plasmid DNA Basic Information
- 9.4.2 FinVector Viral Vector and Plasmid DNA Product Overview
- 9.4.3 FinVector Viral Vector and Plasmid DNA Product Market Performance
- 9.4.4 FinVector Business Overview
- 9.4.5 FinVector Viral Vector and Plasmid DNA SWOT Analysis
- 9.4.6 FinVector Recent Developments
- 9.5 Lonza
- 9.5.1 Lonza Viral Vector and Plasmid DNA Basic Information
- 9.5.2 Lonza Viral Vector and Plasmid DNA Product Overview
- 9.5.3 Lonza Viral Vector and Plasmid DNA Product Market Performance
- 9.5.4 Lonza Business Overview
- 9.5.5 Lonza Viral Vector and Plasmid DNA SWOT Analysis
- 9.5.6 Lonza Recent Developments
- 9.6 BioReliance
- 9.6.1 BioReliance Viral Vector and Plasmid DNA Basic Information
- 9.6.2 BioReliance Viral Vector and Plasmid DNA Product Overview
- 9.6.3 BioReliance Viral Vector and Plasmid DNA Product Market Performance
- 9.6.4 BioReliance Business Overview
- 9.6.5 BioReliance Recent Developments
- 9.7 MolMed
- 9.7.1 MolMed Viral Vector and Plasmid DNA Basic Information
- 9.7.2 MolMed Viral Vector and Plasmid DNA Product Overview
- 9.7.3 MolMed Viral Vector and Plasmid DNA Product Market Performance
- 9.7.4 MolMed Business Overview
- 9.7.5 MolMed Recent Developments
- 9.8 FUJIFILM Diosynth Biotechnologies
- 9.8.1 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Basic Information
- 9.8.2 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Product Overview
- 9.8.3 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Product Market Performance
- 9.8.4 FUJIFILM Diosynth Biotechnologies Business Overview
- 9.8.5 FUJIFILM Diosynth Biotechnologies Recent Developments
- 9.9 UniQure
- 9.9.1 UniQure Viral Vector and Plasmid DNA Basic Information
- 9.9.2 UniQure Viral Vector and Plasmid DNA Product Overview
- 9.9.3 UniQure Viral Vector and Plasmid DNA Product Market Performance
- 9.9.4 UniQure Business Overview
- 9.9.5 UniQure Recent Developments
- 9.10 Aldevron
- 9.10.1 Aldevron Viral Vector and Plasmid DNA Basic Information
- 9.10.2 Aldevron Viral Vector and Plasmid DNA Product Overview
- 9.10.3 Aldevron Viral Vector and Plasmid DNA Product Market Performance
- 9.10.4 Aldevron Business Overview
- 9.10.5 Aldevron Recent Developments
- 9.11 Richter-Helm
- 9.11.1 Richter-Helm Viral Vector and Plasmid DNA Basic Information
- 9.11.2 Richter-Helm Viral Vector and Plasmid DNA Product Overview
- 9.11.3 Richter-Helm Viral Vector and Plasmid DNA Product Market Performance
- 9.11.4 Richter-Helm Business Overview
- 9.11.5 Richter-Helm Recent Developments
- 9.12 Eurogentec
- 9.12.1 Eurogentec Viral Vector and Plasmid DNA Basic Information
- 9.12.2 Eurogentec Viral Vector and Plasmid DNA Product Overview
- 9.12.3 Eurogentec Viral Vector and Plasmid DNA Product Market Performance
- 9.12.4 Eurogentec Business Overview
- 9.12.5 Eurogentec Recent Developments
- 9.13 OBiO Technology
- 9.13.1 OBiO Technology Viral Vector and Plasmid DNA Basic Information
- 9.13.2 OBiO Technology Viral Vector and Plasmid DNA Product Overview
- 9.13.3 OBiO Technology Viral Vector and Plasmid DNA Product Market Performance
- 9.13.4 OBiO Technology Business Overview
- 9.13.5 OBiO Technology Recent Developments
- 9.14 Yposkesi
- 9.14.1 Yposkesi Viral Vector and Plasmid DNA Basic Information
- 9.14.2 Yposkesi Viral Vector and Plasmid DNA Product Overview
- 9.14.3 Yposkesi Viral Vector and Plasmid DNA Product Market Performance
- 9.14.4 Yposkesi Business Overview
- 9.14.5 Yposkesi Recent Developments
- 9.15 Cell and Gene Therapy Catapult
- 9.15.1 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Basic Information
- 9.15.2 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Product Overview
- 9.15.3 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Product Market Performance
- 9.15.4 Cell and Gene Therapy Catapult Business Overview
- 9.15.5 Cell and Gene Therapy Catapult Recent Developments
- 9.16 MassBiologics
- 9.16.1 MassBiologics Viral Vector and Plasmid DNA Basic Information
- 9.16.2 MassBiologics Viral Vector and Plasmid DNA Product Overview
- 9.16.3 MassBiologics Viral Vector and Plasmid DNA Product Market Performance
- 9.16.4 MassBiologics Business Overview
- 9.16.5 MassBiologics Recent Developments
- 9.17 Biovian
- 9.17.1 Biovian Viral Vector and Plasmid DNA Basic Information
- 9.17.2 Biovian Viral Vector and Plasmid DNA Product Overview
- 9.17.3 Biovian Viral Vector and Plasmid DNA Product Market Performance
- 9.17.4 Biovian Business Overview
- 9.17.5 Biovian Recent Developments
- 9.18 VGXI
- 9.18.1 VGXI Viral Vector and Plasmid DNA Basic Information
- 9.18.2 VGXI Viral Vector and Plasmid DNA Product Overview
- 9.18.3 VGXI Viral Vector and Plasmid DNA Product Market Performance
- 9.18.4 VGXI Business Overview
- 9.18.5 VGXI Recent Developments
- 9.19 Gene Synthesis
- 9.19.1 Gene Synthesis Viral Vector and Plasmid DNA Basic Information
- 9.19.2 Gene Synthesis Viral Vector and Plasmid DNA Product Overview
- 9.19.3 Gene Synthesis Viral Vector and Plasmid DNA Product Market Performance
- 9.19.4 Gene Synthesis Business Overview
- 9.19.5 Gene Synthesis Recent Developments
- 9.20 PlasmidFactory
- 9.20.1 PlasmidFactory Viral Vector and Plasmid DNA Basic Information
- 9.20.2 PlasmidFactory Viral Vector and Plasmid DNA Product Overview
- 9.20.3 PlasmidFactory Viral Vector and Plasmid DNA Product Market Performance
- 9.20.4 PlasmidFactory Business Overview
- 9.20.5 PlasmidFactory Recent Developments
- 9.21 Jikai Gene
- 9.21.1 Jikai Gene Viral Vector and Plasmid DNA Basic Information
- 9.21.2 Jikai Gene Viral Vector and Plasmid DNA Product Overview
- 9.21.3 Jikai Gene Viral Vector and Plasmid DNA Product Market Performance
- 9.21.4 Jikai Gene Business Overview
- 9.21.5 Jikai Gene Recent Developments
- 10 Viral Vector and Plasmid DNA Market Forecast by Region
- 10.1 Global Viral Vector and Plasmid DNA Market Size Forecast
- 10.2 Global Viral Vector and Plasmid DNA Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Viral Vector and Plasmid DNA Market Size Forecast by Country
- 10.2.3 Asia Pacific Viral Vector and Plasmid DNA Market Size Forecast by Region
- 10.2.4 South America Viral Vector and Plasmid DNA Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Viral Vector and Plasmid DNA by Country
- 11 Forecast Market by Type and by Application (2024-2029)
- 11.1 Global Viral Vector and Plasmid DNA Market Forecast by Type (2024-2029)
- 11.1.1 Global Forecasted Sales of Viral Vector and Plasmid DNA by Type (2024-2029)
- 11.1.2 Global Viral Vector and Plasmid DNA Market Size Forecast by Type (2024-2029)
- 11.1.3 Global Forecasted Price of Viral Vector and Plasmid DNA by Type (2024-2029)
- 11.2 Global Viral Vector and Plasmid DNA Market Forecast by Application (2024-2029)
- 11.2.1 Global Viral Vector and Plasmid DNA Sales (K Units) Forecast by Application
- 11.2.2 Global Viral Vector and Plasmid DNA Market Size (M USD) Forecast by Application (2024-2029)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook